Universe Pharmaceuticals director files initial Form 3

Universe Pharmaceuticals INC director Pang Jiawen has filed an initial statement of beneficial ownership on Form 3.

Accepted by SEC EDGAR 03/18/2026 - 08:23 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Universe Pharmaceuticals INC director Pang Jiawen has filed an initial statement of beneficial ownership on Form 3. This filing establishes Pang’s status as a director of the company and does not report any stock transactions or holdings at this time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Universe Pharmaceuticals (UPC) Form 3 for Pang Jiawen show?

The Form 3 shows that Pang Jiawen is a director of Universe Pharmaceuticals INC (UPC). It is an initial beneficial ownership filing and reports no stock transactions, derivative positions, or current holdings in the available data.

Does Pang Jiawen buy or sell any UPC shares in this Form 3?

No transactions are reported for Pang Jiawen in this Form 3. The filing lists zero buys, zero sells, and no derivative exercises or gifts, indicating it is purely an initial ownership statement without trading activity disclosed.

What role does Pang Jiawen have at Universe Pharmaceuticals (UPC)?

Pang Jiawen is identified as a director of Universe Pharmaceuticals INC. The Form 3 confirms board-level status, while indicating no officer role, no ten-percent ownership flag, and no other listed positions in the company in this filing.

Are any derivative securities reported for Pang Jiawen in the UPC Form 3?

No derivative securities are reported for Pang Jiawen in this Form 3. The derivative summary is empty, and the transaction summary shows no option exercises or other derivative transactions associated with Universe Pharmaceuticals INC shares.

Does the UPC Form 3 indicate Pang Jiawen’s shareholdings amount?

The available Form 3 data does not list any specific shareholdings for Pang Jiawen. The transaction and holding summaries show zero transactions and no holding entries, making this a structural disclosure of role rather than a detailed position report.

What does a neutral net buy/sell direction mean in this UPC Form 3?

The neutral net buy/sell direction indicates no net trading activity for Pang Jiawen. Buy, sell, and other transaction counts are all zero, so the filing functions as an initial registration of insider status without reflecting market trades.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Pang Jiawen

(Last) (First) (Middle)

265 JINGJIU AVENUE

JINGGANGSHAN ECON. AND TECH. DEV. ZONE

(Street)

JI'AN, JIANGXI 343100

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Universe Pharmaceuticals INC [ UPC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Jiawen Pang	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)